üma Laboratories

Laboratoires üma develops products targeting the physiological changes associated with perimenopause, menopause, and post-menopause.

Health and bio

üma Laboratories raised $2M in a Seed round announced September 18, 2026, according to frenchweb.fr.

Founders and team

• PT
  Priscaël T. Founder

  source: crunchbase.com

Raise history

1. September 18, 2026
   Seed · $2M
   Source: frenchweb.fr

Investors

• DDealClub
• KKima Ventures
• TThe Moon Venture

Related bio health companies

• MM-BasedOct 1, 2026
• AAyna HealthOct 1, 2026
• VVytalYou$830K · Sep 30, 2026
• LLindera USSep 29, 2026
• OOrtet$500M · Sep 29, 2026
• AAptadir Therapeutics$45M · Sep 29, 2026
• GGoerSep 29, 2026
• FFreyyaSep 29, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/uma-laboratories.